David Terry

David Terry

Auto-generated profile, based on publicly available information

David Terry

Aston Pharmacy School, Aston University, Birmingham, UK

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 October 2014 in British Journal of Clinical Pharmacology
Verified
Journal Article
Closed access
PDF file
ALAudrey Lajoinie
Audrey Lajoinie
EHEmilie Henin
Emilie Henin
BKBehrouz Kassai Koupai
Behrouz Kassai Koupai
DTDavid Terry
David Terry

14 May 2013 in Pediatric Drugs
Verified
Journal Article
Closed access
PDF file
CHChi Huynh
Chi Huynh
IWIan Chi Kei Wong
Ian Chi Kei Wong
STStephen Tomlin
Stephen Tomlin
DTDavid Terry
David Terry
ASAnthony Sinclair
Anthony Sinclair
YJYogini Jani
Yogini Jani

26 November 2018 in International Journal of Clinical Pharmacy
Verified
Journal Article
Open access
PDF file
JAJeff Aston
Jeff Aston
KWKeith A. Wilson
Keith A. Wilson
DTDavid R. P. Terry
David R. P. Terry
Background Taking regular medication has been shown to have an impact on the daily lives of patients and their families. Objective To explore the medication-related experiences of patients and their families when a child or young person is prescribed regular medication. Setting A specialist U.K. paediatric hospital. Method Semi-structured face-to-face interviews of 24 parents/carers, children or young people, who had been taking two or more medications for 6 weeks or longer. The themes explored included the medication regimen, formulation, supplies, social aspects and adverse effects. The data was analysed using NVIVO version 11. Main outcome measure The experiences of patients, and their parents/carers, when a child/young person takes regular medication. Results Participants described a range of experiences associated with taking regular medication. Medication-related challenges were experienced around the timing of administration which was managed over 24 h rather than waking hours. Updating medication doses for administration at school was often delayed. Unintended nonadherence was cited as the biggest challenge with a range of strategies employed to manage this. The internet was commonly used as a source of additional information accessed for reassurance and adverse effects but there were varying experiences of using patient forums/help groups. Other challenges included the adequacy of information, travelling with medication, formulation issues, arranging supplies and adverse effects. Conclusion Patients and parents experience many challenges with children’s medication. Individualised treatment options should be considered. Further research is required to determine how these experiences may be managed including the role of paediatric medication review.

2 September 2016 in European Journal of Hospital Pharmacy
Verified
Journal Article
Closed access
PDF file
HAHamad Alyami
Hamad Alyami
EDEman Zmaily Dahmash
Eman Zmaily Dahmash
FAFahad Alyami
Fahad Alyami
DDDania Dahmash
Dania Dahmash
CHChi Huynh
Chi Huynh
Afzal MohammedAfzal Mohammed
Afzal Mohammed
Objectives The current study aims to evaluate dosage form preferences in children and young adults together with identifying the key pragmatic dosage form characteristics that would enable appropriate formulation of orally disintegrating tablets (ODTs). Methods International, multisite, cross-sectional questionnaire of children and young adults aged from 6 to 18 years. Eligibility was based on age, ability to communicate and previous experience in taking medications. The study was carried out at three locations: the UK, Saudi Arabia and Jordan. The questionnaire instrument was designed for participant self-completion under supervision of the study team. Results 104 questionnaires were completed by the study cohort (n=120, response rate 87%). Results showed that ODTs were the most preferred oral dosage forms (58%) followed by liquids (20%), tablets (12%) and capsules (11%). The preferred colours were pink or white while the preferred size was small (<8 mm) with a round shape. With regard to flavour, strawberry was the most preferred (30.8%), while orange was the least preferred (5.8%). The results also showed that the most important physical characteristics of ODTs were disintegration time followed by taste, size and flavour, respectively. Conclusions The results of our study support the WHO’s claim for a shift of paradigm from liquid towards ODTs dosage forms for drug administration to young children older than 6 years. Data from this study will also equip formulators to prioritise development of key physical/performance attributes within the delivery system.

13 November 2015 in Archives of Disease in Childhood
Verified
Journal Article
Closed access
PDF file
CHChi Huynh
Chi Huynh
STStephen Tomlin
Stephen Tomlin
YJYogini Jani
Yogini Jani
GSGuirish A Solanki
Guirish A Solanki
HHHelen Haley
Helen Haley
DTDavid Terry
David Terry
Aims To determine the incidence of unintended medication discrepancies in paediatric patients at the time of hospital admission; evaluate the process of medicines reconciliation; assess the benefit of medicines reconciliation in preventing clinical harm. Method A 5 month prospective multisite study. Pharmacists at four English hospitals conducted admission medicines reconciliation in children using a standardised data collection form. A discrepancy was defined as a difference between the patient's preadmission medication (PAM), compared with the initial admission medication orders written by the hospital doctor. The discrepancies were classified into intentional and unintentional discrepancies. The unintentional discrepancies were assessed for potential clinical harm by a team of healthcare professionals, which included doctors, pharmacists and nurses. Results Medicines reconciliation was conducted in 244 children admitted to hospital. 45% (109/244) of the children had at least one unintentional medication discrepancy between the PAM and admission medication order. The overall results indicated that 32% (78/244) of patients had at least one clinically significant unintentional medication discrepancy with potential to cause moderate 20% (50/244) or severe 11% (28/244) harm. No single source of information provided all the relevant details of a patient's medication history. Parents/carers provided the most accurate details of a patient's medication history in 81% of cases. Conclusions This study demonstrates that in the absence of medicines reconciliation, children admitted to hospitals across England are at risk of harm from unintended medication discrepancies at the transition of care from the community to hospital. No single source of information provided a reliable medication history.

1 February 2017 in Journal of Adolescent Health
Verified
Journal Article
Open access
NGNicola Gray
Nicola Gray
KSKaren L. Shaw
Karen L. Shaw
FSFelicity Smith
Felicity Smith
JBJonathan Burton
Jonathan Burton
Julie PrescottJulie Prescott
Julie Prescott
JMJanet E. McDonagh
Janet E. McDonagh
To explore the perceived and potential roles of pharmacists in the care of young people aged 10-24 years with chronic illness, through the exemplar of juvenile arthritis, from the perspectives of UK community and hospital pharmacists, health service commissioners, rheumatology health professionals, and lay advocates. A sequential mixed methods study design comprises the following: focus groups with community and hospital pharmacists; telephone interviews with pharmacy and rheumatology stakeholders and commissioners; and multidisciplinary group discussions to prioritize roles generated by the first two qualitative phases. The high priority roles for pharmacists, identified by pharmacists and rheumatology staff, were developing generic health care skills among young people; transferring information effectively across care interfaces; building trusting relationships with young people; helping young people to find credible online health information; and the need to develop specialist expertise. Participants identified associated challenges for pharmacists in supporting young people with chronic illness. These challenges included parents collecting prescription refills alone, thus reducing opportunities to engage, and pharmacist isolation from the wider health care team. This study has led to the identification of specific enhancements to pharmacy services for young people, which have received the endorsement of a wide range of stakeholders. These suggestions could inform the next steps in developing the contribution of community and hospital pharmacy to support young people with chronic illness in the optimal use of their medication.